Company intelligence / Profile preview

MetaNovas Biotech

Foster City, California, United Statesmetanovas.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

MetaNovas has demonstrated efficacy in rapid R&D cycles using AI-driven platforms. Their peptides have shown significant results in reducing acne lesions within 7 days and improving signs of aging by targeting cellular senescence. The company’s approach enables faster market entry of novel ingredients with validated biological activity[5][6].

Therapeutic areas: DermatologyWomen's HealthInfectious Diseases
Modalities: PeptidesSmall moleculeFunctional polypeptidesBioactive ingredients (for cosmeceuticals/nutraceuticals)
Industry: Non-Drug Biotech

Partnerships

L'OréalBeiersdorfHaleonTakedaUnilever

Beyond the preview

Go deeper on MetaNovas Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaNovas Biotech.

Explore the full profile